U
CBPO

UBS’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

UBS’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$54K Buy
+1,000
New +$49.2K ﹤0.01% 6736
2014
Q2 		– Sell
-1,137
Closed -$40K – 11103
2014
Q1 		$40K Sell
1,137
-218
-16% -$6.94K ﹤0.01% 7156
2013
Q4 		$39K Buy
+1,355
New +$39.3K ﹤0.01% 7300

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EMR
Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS's CBPO Position: Q3 2014 in Review

UBS opened a new position in China Biologic Products Holdings, Inc. (CBPO) in Q3 2014: 1,000 shares worth $54K. The stake represents ﹤0.01% of the portfolio and ranks #6736 among its holdings. This is a return to the name: UBS previously reported a position in CBPO as recently as Q1 2014.

UBS first reported a position in CBPO in Q4 2013 and has held it in 3 quarters since. 54 funds tracked by Wall St. Rank hold CBPO as of Q3 2014.

  • UBS held 1,000 shares of China Biologic Products Holdings, Inc. worth $54K as of Q3 2014.
  • China Biologic Products Holdings, Inc. was a new UBS position in Q3 2014.
  • China Biologic Products Holdings, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6736 holding.
  • UBS first reported a position in China Biologic Products Holdings, Inc. in Q4 2013 and has held it in 3 quarters since.
  • 54 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.